B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Damnacanthal

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Damnacanthal, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

lx
2 shared targets
pha
2 shared targets
gandotinib
2 shared targets
tanzisertib
2 shared targets
encorafenib
2 shared targets
aee
2 shared targets
asp
3 shared targets
capivasertib
2 shared targets
dabrafenib
3 shared targets
golvatinib
2 shared targets
Loading evidence profile...

This evidence profile for Damnacanthal is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.